Split History
NBS split history picture
NBS (NBS) has 2 splits in our NBS split history database. The first split for NBS took place on August 09, 2007. This was a 1 for 10 reverse split, meaning for each 10 shares of NBS owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split. NBS's second split took place on July 16, 2013. This was a 1 for 10 reverse split, meaning for each 10 shares of NBS owned pre-split, the shareholder now owned 1 share. For example, a 100 share position pre-split, became a 10 share position following the split.

When a company such as NBS conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the NBS split history from start to finish, an original position size of 1000 shares would have turned into 10 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into NBS shares, starting with a $10,000 purchase of NBS, presented on a split-history-adjusted basis factoring in the complete NBS split history. NBS split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 12/10/2012
End date: 06/05/2015
Start price/share: $6.20
End price/share: $2.25
Dividends collected/share: $0.00
Total return: -63.71%
Average Annual Total Return: -33.53%
Starting investment: $10,000.00
Ending investment: $3,628.46
Years: 2.48
NeoStem is engaged in the development of proprietary cell therapy products, and operating a contract development and manufacturing organization providing services in the regenerative medicine industry. Co. is developing therapies to address ischemia through its CD34 Cell Program. AMR-001 is Co.'s product candidate in this program and is being developed to treat damaged heart muscle following an acute myocardial infarction (heart attack). Another platform technology Co. is developing uses T Regulatory Cells to treat diseases caused by imbalances in the immune system. In addition, pre-clinical assets include Co.'s VSEL™ (Very Small Embryonic Like) Technology regenerative medicine platform. According to our NBS split history records, NBS has had 2 splits.
Date Ratio
08/09/20071 for 10
07/16/20131 for 10
NBS is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

NBY Split History
NEOG Split History
NERV Split History
NMRD Split History
NMTR Split History
NNVC Split History
NOVN Split History
NRBO Split History
NRCIB Split History
NSPH Split History

Email EnvelopeFree NBS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Checkpoint Therapeutics, Inc. (CKPT)
UpHealth, Inc. (UPH)
MediWound Ltd. (MDWD)
Eloxx Pharmaceuticals, Inc. (ELOX)
Baudax Bio, Inc. (BXRX)
Petros Pharmaceuticals, Inc. (PTPI)
Tuesday Morning Corporation (TUEM)
DURECT Corporation (DRRX)
CNS Pharmaceuticals, Inc. (CNSP)
Astrotech Corporation (ASTC)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

NBS Insider Buying

NBS Split History | www.SplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.